Their bill was recently tied to the Food and Drug Administration Safety and Landmark Advancement Act (FDASLA) , creating new regulatory barriers and giving the FDA new authority to prevent health and wellness products from reaching millions of consumers.
Sadly, Senator Braun and Durbin are using their dislike of the dietary supplement industry to misrepresent the industry's excellent safety record. The FDASLA is intended for drugs, not supplements, and we can not afford to allow critics of the industry to stifle the industry.
Don't let Senators Braun and Durbin threaten your access to dietary supplements. Let Congress know you oppose pre-market approval for dietary supplements.
Daniel Fabricant, Ph.D.
President and CEO
Natural Products Association